New Non-Antibiotic BV treatment shows promise in early safety testing
NCT ID NCT07394777
Summary
This study is testing the safety of a new vaginal tablet called pHyph for treating bacterial vaginosis (BV). Thirty-two women with BV will use the tablets for 12 days while researchers monitor for any side effects. The treatment aims to restore the vagina's natural acidity to help good bacteria grow and control BV symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BACTERIAL VAGINOSIS (BV) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CMedical
RECRUITINGUppsala, Sweden
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CTC Stockholm
RECRUITINGSolna, Sweden
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.